Acticor Biotech (France) Today
Acticor Biotech is selling at 0.25 as of the 22nd of March 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.25. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Valuation
Check how we calculate scores
Acticor Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Acticor Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Acticor Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Julien Parrou |
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Communication Services, Media, Advertising Agencies, Communication Services, Computing (View all Sectors) |
Acticor Biotech SAS (ALACT) is traded on Euronext Paris in France and employs 25 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acticor Biotech's market, we take the total number of its shares issued and multiply it by Acticor Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Acticor Biotech SAS operates under Media sector and is part of Communication Services industry. The entity has 10.52 M outstanding shares.
Acticor Biotech SAS has accumulated about 571.18 K in cash with (13.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check Acticor Biotech Probability Of Bankruptcy
Acticor Biotech SAS Risk Profiles
Although Acticor Biotech's alpha and beta are two of the key measurements used to evaluate Acticor Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.4179 | |||
| Standard Deviation | 1.06 | |||
| Variance | 1.12 | |||
| Risk Adjusted Performance | (0.18) |
Acticor Stock Against Markets
| ALACT | 0.00 |
|
| Competition | Refresh |
Acticor Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acticor Biotech stock to make a market-neutral strategy. Peer analysis of Acticor Biotech could also be used in its relative valuation, which is a method of valuing Acticor Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Acticor Biotech Corporate Directors
| Patrice Coffe | Administrative and Financial Director, Member of the Board | Profile | |
| Hugues Duboscq | Director - Permanent Representative of Saint-Florentin Participations | Profile | |
| Jerome Leleu | Director | Profile | |
| Frederic Bartoli | Director - Representative of Chorus | Profile |
Additional Tools for Acticor Stock Analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.